Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease.

Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease.
复制标题

树突状细胞干预在炎症性肠病治疗中的新作用

DOI:
10.1155/2022/7025634
复制
发表时间:
2022
影响因子:
--
通讯作者:
--
中科院分区:
生物学3区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

树突状细胞(Dendritic cells,DC)是最重要的抗原提呈细胞,在启动有效的适应性免疫应答、诱导免疫耐受和维持免疫稳态中起着关键作用。炎症性肠病(Inflammatory bowel disease,IBD)是一种慢性肠道炎症性自身免疫性疾病,包括克罗恩病和溃疡性结肠炎。DC参与IBD的发病机制。本文就树突状细胞在炎症性肠病中的作用及其相互关系作一综述,并强调树突状细胞在炎症性肠病治疗中的重要作用。
Dendritic cells (DCs) are the most important antigen-presenting cells and are pivotal in initiating effective adaptive immune responses to induce immune tolerance and maintain immune homeostasis. Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is chronic, intestinal inflammatory and autoimmune disorder. DCs participate in IBD pathogenesis. This review is aimed at briefly discussing the role of DCs in IBD and the relationship between them and highlighting the prominent role of these cells in the treatment of these disorders.
DOI: 10.1053/j.gastro.2020.09.056
发表时间: 2021-01
期刊: Gastroenterology
影响因子: 29.4
作者:
Lee M;Chang EB
通讯作者: Chang EB
DOI: 10.1038/nri3312
发表时间: 2012-10-01
影响因子: 100.3
作者:
Klaenhammer, Todd R.;Kleerebezem, Michiel;Rescigno, Maria
通讯作者: Rescigno, Maria
DOI: 10.1097/mib.0000000000001204
发表时间: 2017-09-01
影响因子: 4.9
作者:
Matsuno, Hiroshi;Kayama, Hisako;Mizushima, Tsunekazu
通讯作者: Mizushima, Tsunekazu
DOI: 10.1053/j.gastro.2020.04.074
发表时间: 2020-08
期刊: Gastroenterology
影响因子: 29.4
作者:
Mitsialis V;Wall S;Liu P;Ordovas-Montanes J;Parmet T;Vukovic M;Spencer D;Field M;McCourt C;Toothaker J;Bousvaros A;Boston Children’s Hospital Inflammatory Bowel Disease Center;Brigham and Women’s Hospital Crohn’s and Colitis Center;Shalek AK;Kean L;Horwitz B;Goldsmith J;Tseng G;Snapper SB;Konnikova L
通讯作者: Konnikova L
DOI: 10.1111/cei.12870
发表时间: 2017-01-01
影响因子: 4.6
作者:
Anderson, A. E.;Swan, D. J.;Hilkens, C. M. U.
通讯作者: Hilkens, C. M. U.